Macquarie Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Macquarie Group’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-686	Closed	-$23K	–	2704
2021 Q2	$23K	Sell	686 -45,681	-99%	-$1.16M	﹤0.01%	2342
2021 Q1	$1.08M	Buy	46,367 +45,471	+5,075%	+$1.38M	﹤0.01%	1377
2020 Q4	$26K	Hold	896	–	–	﹤0.01%	2172
2020 Q3	$18K	Hold	896	–	–	﹤0.01%	2190
2020 Q2	$27K	Buy	+896	New	+$32.3K	﹤0.01%	2097

Macquarie Group's CNST Position: Q3 2021 in Review

Macquarie Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 686 shares — an estimated $23K sold.

Macquarie Group first reported a position in CNST in Q2 2020 and held it in 5 quarters. The position peaked at $1.08M in Q1 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Macquarie Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Macquarie Group sold 686 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $23K.
Macquarie Group first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 5 quarters.
Macquarie Group's Constellation Pharmaceuticals, Inc. position peaked at $1.08M in Q1 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Macquarie Group's 13F filing for Q3 2021, filed 12 Nov 2021.